ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2670

Does Change In Femorotibial Cartilage Thickness Differ Between Acutely Anterior-Cruciate Ligament Injured Knees Treated With and Without Reconstructive Surgery

Wolfgang Wirth1, Felix Eckstein1, Martin Hudelmaier2, Stefan Lohmander3 and Richard Frobell4, 1Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, 2Paracelsus Medical University, Salzburg, Austria, 3Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, 4Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, injury, Knee, magnetic resonance imaging (MRI) and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis I: Therapeutics in Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: An ACL tear is a serious knee injury, involving chronic alterations in joint biomechanics. The risk of developing knee OA after an ACL tear is elevated, but the driving mechanisms are not known. We tested the hypothesis that surgical reconstruction of an acute ACL tear would influence change in femorotibial cartilage thickness over the first five years after injury.

Methods: In a treatment RCT (the KANON-trial), 121 young (32 women, mean age 26.1 years) active adults with an acute ACL tear in a previously un-injured knee received similar rehabilitation. Baseline sagittal MR images were available for 117 participants, with year 2 and year 5 follow-up for each 112 of the 121 participants. 59 of those underwent an early ACL reconstruction (ACLR), 29 had a delayed ACLR, and 29 were treated with rehab alone. Cartilage thickness (ThC) was measured manually with blinding to time point and treatment using a dedicated software (Chondrometrics GmbH, Ainring, Germany). Primary outcome was the mean change in ThC for the entire femorotibial joint (FTJ); secondary outcomes were mean change in ThC for the medial and the lateral femorotibial compartments (MFTC/LFTC), the subregion with the largest ThC loss (ordered value 1 = OV1) and gain (OV16). ThC changes were analyzed using the t-test (crude differences) and analysis of covariance (differences with adjustment for age, sex & BMI).

Results:

The cartilage thickness change over 5 years in the FTJ did not differ significantly between knees treated with early ACLR (+148µm, 95%CI: [+38, +258]µm), with delayed ACLR (+174 [+42, +306]µm), or with rehabilitation alone (+121 [-3,+246]µm, crude/adjusted p≥0.56/0.65). In addition, no significant differences were found for the periods between BL→Y2 and Y2→Y5. The change in FTJ ThC was largely driven by change in MFTC ThC (early ACLR: +132 [+77, +187] µm, delayed ACLR: +128 [+40, +216] µm, rehab alone: +82 [+19, +146] µm), but without significant differences between treatment groups over the entire 5 year period (p≥0.28/0.20) or for the sub-periods (p≥0.19/0.20). Smaller changes, not significantly different between treatment groups (p≥0.60/0.70), were observed in LFTC (early ACLR: +16 [-53, +85] µm, delayed ACLR: +46[-25, +116] µm, rehab alone: +39 [-46, +124] µm).

OV 1 was significantly more negative and OV 16 was significantly more positive over 5 years in knees treated with early ACLR than in knees treated with rehab alone (OV1: p=0.04/0.03; OV16: p=0.02/0.01). These differences were predominantly driven by changes occurring between BL→Y2 with OV1 being significantly more negative in knees with early (p=0.01/0.01) or delayed ACLR (p=0.04/0.04) compared to knees treated with rehab alone. No other significant differences were found for any period.

Conclusion: Change in mean femorotibial cartilage thickness over a five year period after acute ACL injury did not differ between knees treated with early or delayed ACL reconstruction or knees treated with rehabilitation alone. An early ACL reconstruction may induce greater magnitudes of subregional cartilage thickness change as compared to knees treated with rehabilitation alone but the clinical relevance of such change remains to be determined.


Disclosure:

W. Wirth,

Chondrometrics GmbH, Ainring, Germany,

4,

Chondrometrics GmbH, Ainring, Germany,

3;

F. Eckstein,

Chondrometrics GmbH,

4,

MerckSerono,

5,

Sanofi Aventis,

5,

Abbot ,

5,

Synarc,

5,

GlaxoSmithKline,

4,

Genzyme,

5,

Medtronic,

5,

Synthes,

5,

Pfizer,

2,

Eli Lilly and Company,

2,

MerckSerono,

2,

GlaxoSmithKline,

2,

Centocor ,

2,

Wyeth Pharmaceuticals,

2,

Novartis Pharmaceutical Corporation,

2,

Stryker,

2;

M. Hudelmaier,
None;

S. Lohmander,
None;

R. Frobell,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-change-in-femorotibial-cartilage-thickness-differ-between-acutely-anterior-cruciate-ligament-injured-knees-treated-with-and-without-reconstructive-surgery/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology